TESAMORELIN
Synthetic GHRH analogue for GH-releasing research. 40+ peer-reviewed preclinical studies. 3-lab independent COA on every batch.
What is Tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It consists of a modified 44-amino-acid GHRH sequence designed to stimulate growth hormone release from the anterior pituitary. It is the only GHRH analogue that has received FDA approval in pharmaceutical form for a specific indication — the research-grade version is used for preclinical study of the GH axis.
With 40+ preclinical publications, Tesamorelin has been studied extensively in models of visceral adiposity reduction, GH axis restoration, body composition modulation, and lipodystrophy-related metabolic signaling.
Published preclinical research areas
Visceral adiposity models
Studied in preclinical models examining visceral fat reduction through GH-mediated lipolysis pathways. Research explores selective reduction of trunk adipose tissue without altering subcutaneous fat compartments.
GH axis restoration
Preclinical studies examine Tesamorelin's ability to restore pulsatile GH release patterns through GHRH receptor activation. Research has explored age-related GH decline models and feedback loop restoration.
Body composition signaling
Research examines changes in lean mass to fat mass ratio, IGF-1 pathway activation, and metabolic rate modulation in preclinical models of body composition optimization.
Lipodystrophy research
Extensive preclinical and translational research on Tesamorelin's role in lipodystrophy-related fat redistribution models, including HIV-associated lipodystrophy signaling pathways.
SMART MD quality standard for Tesamorelin
- HPLC purity analysis — identity and purity confirmed via high-performance liquid chromatography.
- Mass spectrometry — molecular weight confirmation. Verifies correct peptide sequence.
- LAL endotoxin assay — <5 EU/mg. Bacterial endotoxin safety verification.
- 3 independent U.S. laboratories — rotating panel. No single lab relationship can compromise verification integrity.
- Lot-specific COA — publicly verifiable at smartmdpeptides.com/verify before you order.
Tesamorelin FAQ
Where can I buy research-grade Tesamorelin?+
Research-grade Tesamorelin with 3-lab COA verification is available at SMART MD Peptides in 5mg ($66.98) and 10mg ($89.98) formulations. Every batch is publicly verifiable at smartmdpeptides.com/verify.
What is the purity of SMART MD's Tesamorelin?+
Every Tesamorelin batch is third-party tested with a published COA. Each batch is independently verified by 3 U.S. laboratories — HPLC for purity, mass spectrometry for molecular weight, and LAL endotoxin assay for safety.
What makes Tesamorelin unique among GHRH peptides?+
Tesamorelin is the only GHRH analogue that received FDA approval in pharmaceutical form for a specific indication. The research-grade version available at SMART MD is for preclinical study of the GH axis, visceral adiposity, and body composition models.
Is Tesamorelin legal for research?+
Tesamorelin is legal to acquire for research purposes. It is classified as a research-use-only compound — not intended for human consumption in this form. Licensed researchers and physicians may acquire it for use in research protocols.
How should Tesamorelin be stored?+
Lyophilized (unreconstituted) Tesamorelin should be stored at -20°C, protected from light. Once reconstituted, store at 2-8°C and use within the timeframe specified on your lot-specific documentation.
Ready to verify?
Check the COA before you buy. Compare it against any other supplier's documentation.